203 related articles for article (PubMed ID: 16409183)
1. Rituximab in the treatment of high responding inhibitors in severe haemophilia A.
Moschovi M; Aronis S; Trimis G; Platokouki H; Salavoura K; Tzortzatou-Stathopoulou F
Haemophilia; 2006 Jan; 12(1):95-9. PubMed ID: 16409183
[TBL] [Abstract][Full Text] [Related]
2. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
Field JJ; Fenske TS; Blinder MA
Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
[TBL] [Abstract][Full Text] [Related]
3. Rituximab for adolescents with haemophilia and high titre inhibitors.
Fox RA; Neufeld EJ; Bennett CM
Haemophilia; 2006 May; 12(3):218-22. PubMed ID: 16643204
[TBL] [Abstract][Full Text] [Related]
4. Rituximab as a single agent in the management of adult patients with haemophilia A and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor.
Aleem A; Saidu A; Abdulkarim H; Al-Diab AR; Al-Sagheer A; Qayum A; Al-Momen AK
Haemophilia; 2009 Jan; 15(1):210-6. PubMed ID: 19149851
[TBL] [Abstract][Full Text] [Related]
5. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor treatment by rituximab in congenital haemophilia A - Two case reports.
Streif W; Escuriola Ettingshausen C; Linde R; Kropshofer G; Zimmerhackl LB; Kreuz W
Hamostaseologie; 2009 May; 29(2):151-4. PubMed ID: 19404522
[TBL] [Abstract][Full Text] [Related]
7. Rituximab treatment of mild haemophilia A with inhibitors: a proposed treatment protocol.
Dunkley S; Kershaw G; Young G; Warburton P; Lindeman R; Matthews S; Rennisson F
Haemophilia; 2006 Nov; 12(6):663-7. PubMed ID: 17083518
[TBL] [Abstract][Full Text] [Related]
8. Novel therapies for immune tolerance in haemophilia A.
Collins PW
Haemophilia; 2006 Dec; 12 Suppl 6():94-100; discussion 100-1. PubMed ID: 17123401
[TBL] [Abstract][Full Text] [Related]
9. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience.
Carcao M; St Louis J; Poon MC; Grunebaum E; Lacroix S; Stain AM; Blanchette VS; Rivard GE;
Haemophilia; 2006 Jan; 12(1):7-18. PubMed ID: 16409170
[TBL] [Abstract][Full Text] [Related]
11. Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.
Mathias M; Khair K; Hann I; Liesner R
Br J Haematol; 2004 May; 125(3):366-8. PubMed ID: 15086418
[TBL] [Abstract][Full Text] [Related]
12. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
Kubisz P; Plamenová I; Hollý P; Stasko J
Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
[TBL] [Abstract][Full Text] [Related]
13. Current and future approaches to inhibitor management and aversion.
Hay C; Recht M; Carcao M; Reipert B
Semin Thromb Hemost; 2006 Jun; 32 Suppl 2():15-21. PubMed ID: 16804831
[TBL] [Abstract][Full Text] [Related]
14. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
Gringeri A; Musso R; Mazzucconi MG; Piseddu G; Schiavoni M; Pignoloni P; Mannucci PM;
Haemophilia; 2007 Jul; 13(4):373-9. PubMed ID: 17610550
[TBL] [Abstract][Full Text] [Related]
15. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.
Hay CR; Ludlam CA; Colvin BT; Hill FG; Preston FE; Wasseem N; Bagnall R; Peake IR; Berntorp E; Mauser Bunschoten EP; Fijnvandraat K; Kasper CK; White G; Santagostino E
Thromb Haemost; 1998 Apr; 79(4):762-6. PubMed ID: 9569189
[TBL] [Abstract][Full Text] [Related]
16. Humoral immune responsiveness to a defined epitope on factor VIII before and after B cell ablation with rituximab.
Kessel C; Königs C; Linde R; Escuriola-Ettinghausen C; Stoll H; Klingebiel T; Dietrich U; Kreuz W
Mol Immunol; 2008 Nov; 46(1):8-15. PubMed ID: 18715645
[TBL] [Abstract][Full Text] [Related]
17. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
[TBL] [Abstract][Full Text] [Related]
18. Successful rituximab therapy of acquired factor VIII inhibitor in a patient with rheumatoid arthritis.
Oliveira B; Arkfeld DG; Weitz IC; Shinada S; Ehresmann G
J Clin Rheumatol; 2007 Apr; 13(2):89-91. PubMed ID: 17414538
[TBL] [Abstract][Full Text] [Related]
19. Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low-dose regimens.
Lin PC; Liao YM; Tsai SP; Chang TT
Pediatr Blood Cancer; 2011 Dec; 57(6):1029-33. PubMed ID: 21793191
[TBL] [Abstract][Full Text] [Related]
20. Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature.
Alvarado Y; Yao X; Jumper C; Hardwicke F; D'Cunha N; Cobos E
Clin Appl Thromb Hemost; 2007 Oct; 13(4):443-8. PubMed ID: 17911199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
